Bausch Health names hedge fund manager John Paulson as chairperson
Advertisement
Read this article for free:
or
Already have an account? Log in here »
To continue reading, please subscribe:
Digital Subscription
One year of digital access for only $1.44 a week*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Billed as $5.77 plus GST every four weeks. After 52 weeks, price increases to the regular rate of $19.95 plus GST every four weeks. Offer available to new and qualified returning subscribers only. Cancel any time.
To continue reading, please subscribe:
Add Free Press access to your Brandon Sun subscription for only an additional
$1 for the first 4 weeks*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Your next Brandon Sun subscription payment will increase by $1.00 and you will be charged $17.95 plus GST for four weeks. After four weeks, your payment will increase to $24.95 plus GST every four weeks.
Read unlimited articles for free today:
or
Already have an account? Log in here »
Hey there, time traveller!
This article was published 24/06/2022 (1585 days ago), so information in it may no longer be current.
LAVAL, Que. – Bausch Health Companies Inc. says hedge fund manager John Paulson has been named chairperson of its board of directors, replacing Joseph Papa.
Paulson is president and portfolio manager of Paulson & Co. Inc., an investment management company, which he founded in 1994.
He previously served on the board of Bausch Health from June 2017 to May 2022.
The company says Papa’s decision to resign from the board was not due to any dispute or disagreement with the company, its management or the board.
Papa, who stepped down as chief executive of Bausch Health earlier this year, remains chairman and chief executive of Bausch + Lomb Corp., which recently completed its initial public offering and is being spun off from Bausch Health.
Paulson is an independent director of Bausch + Lomb.
This report by The Canadian Press was first published June 24, 2022.
Companies in this story: (TSX:BHC, TSX:BLCO)